DES

DIETHYLSTILBESTROL

Created:	1999-07-08
Last modified:	2011-06-04

Find Related PDB Entry
5 entries where DES is found as a standalone ligand

Help Find related ligands:
Similar Ligands (Stereospecific) Similar Ligands (including Stereoisomers) Similar Ligands (Quick Screen) Similar Ligands (Substructure Stereospecific) Similar Ligands (Substructure including Stereoisomers)

Help

Find related ligands:

Similar Ligands (Stereospecific) Similar Ligands (including Stereoisomers) Similar Ligands (Quick Screen) Similar Ligands (Substructure Stereospecific) Similar Ligands (Substructure including Stereoisomers)

Chemical Details
Formal Charge	0
Atom Count	40
Chiral Atom Count	0
Bond Count	41
Aromatic Bond Count	12

WebGL does not seem to be available.

This can be caused by an outdated browser, graphics card driver issue, or bad weather. Sometimes, just restarting the browser helps. Also, make sure hardware acceleration is enabled in your browser.

For a list of supported browsers, refer to http://caniuse.com/#feat=webgl.

Toggle Hydrogen Toggle Labels

Chemical Component Summary
Name	DIETHYLSTILBESTROL
Systematic Name (OpenEye OEToolkits)	4-[(E)-4-(4-hydroxyphenyl)hex-3-en-3-yl]phenol
Formula	C₁₈ H₂₀ O₂
Molecular Weight	268.35
Type	NON-POLYMER

Chemical Descriptors
Type	Program	Version	Descriptor
SMILES	ACDLabs	10.04	Oc2ccc(/C(=C(/c1ccc(O)cc1)CC)CC)cc2
SMILES	CACTVS	3.341	CCC(c1ccc(O)cc1)=C(CC)c2ccc(O)cc2
SMILES	OpenEye OEToolkits	1.5.0	CCC(=C(CC)c1ccc(cc1)O)c2ccc(cc2)O
Canonical SMILES	CACTVS	3.341	CC\C(c1ccc(O)cc1)=C(CC)/c2ccc(O)cc2
Canonical SMILES	OpenEye OEToolkits	1.5.0	CC/C(=C(/CC)\c1ccc(cc1)O)/c2ccc(cc2)O
InChI	InChI	1.03	InChI=1S/C18H20O2/c1-3-17(13-5-9-15(19)10-6-13)18(4-2)14-7-11-16(20)12-8-14/h5-12,19-20H,3-4H2,1-2H3/b18-17+
InChIKey	InChI	1.03	RGLYKWWBQGJZGM-ISLYRVAYSA-N

Drug Info: DrugBank

DrugBank ID	DB00255
Name	Diethylstilbestrol
Groups	withdrawn approved investigational
Description	A synthetic nonsteroidal estrogen used in the treatment of menopausal and postmenopausal disorders. It was also used formerly as a growth promoter in animals. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), diethylstilbestrol has been listed as a known carcinogen. (Merck, 11th ed) The FDA withdrew its approval for the use of all oral and parenteral drug products containing 25 milligrams or more of diethylstilbestrol per unit dose.[L43942]
Synonyms	Diethylstilbestrol Diethylstilbestrol diphosphate sodium 4,4'-dihydroxy-α,β-diethylstilbene trans-Diethylstilboesterol α,α'-diethyl-(E)-4,4'-stilbenediol Dietilestilbestrol DES trans-Diethylstilbestrol Diéthylstilbestrol (E)-3,4-bis(4-hydroxyphenyl)-3-hexene trans-Diethylstilbesterol Diethylstilbestrolum trans-4,4'-(1,2-diethyl-1,2-ethenediyl)bisphenol Diethylstilbestrol diphosphate Stilboestrol (E)-4,4'-(1,2-diethyl-1,2-ethenediyl)bisphenol
Brand Names	Stilbestrol 1.0mg Tablet Honvol Ampoules 250mg Stilbestrol Tablets 0.1 mg Stilbestrol 0.5mg Tablet Stilbestrol Tab 1mg Honvol Tablets 100mg Stilboestrol Tab 0.1mg Stilbestrol Tablets 1.0 mg Stilboestrol Tab 0.5mg Stilbestrol Tablets 0.5 mg
Indication	Used in the treatment of prostate cancer. Previously used in the prevention of miscarriage or premature delivery in pregnant women prone to miscarriage or premature delivery.
Categories	Adrenal Cortex Hormones Antineoplastic Agents, Hormonal Antineoplastic and Immunomodulating Agents BCRP/ABCG2 Inhibitors Benzene Derivatives Benzylidene Compounds BSEP/ABCB11 Substrates Carcinogens COMT Substrates Contraceptive Agents, Female Contraceptive Agents, Male Contraceptives, Postcoital Cytochrome P-450 CYP2C8 Inhibitors Cytochrome P-450 CYP2C8 Inhibitors (strength unknown) Cytochrome P-450 CYP2C8 Substrates Cytochrome P-450 CYP2C9 Inhibitors Cytochrome P-450 CYP2C9 Inhibitors (strength unknown) Cytochrome P-450 CYP2E1 Inhibitors Cytochrome P-450 CYP2E1 Inhibitors (strong) Cytochrome P-450 CYP3A Inhibitors Cytochrome P-450 CYP3A Substrates Cytochrome P-450 CYP3A4 Inhibitors Cytochrome P-450 CYP3A4 Inhibitors (strength unknown) Cytochrome P-450 CYP3A4 Substrates Cytochrome P-450 Enzyme Inhibitors Cytochrome P-450 Substrates Endocrine Therapy Estrogen Contraceptives Estrogens Estrogens, Non-Steroidal Genito Urinary System and Sex Hormones Hormonal Contraceptives for Systemic Use Hormones Hormones and Related Agents Hormones, Hormone Substitutes, and Hormone Antagonists Noxae OATP1B1/SLCO1B1 Inhibitors OATP2B1/SLCO2B1 substrates P-glycoprotein substrates Sex Hormones and Modulators of the Genital System Stilbenes Stilbestrols Synthetic Estrogens, Plain Thyroxine-binding globulin inducers Toxic Actions
ATC-Code	L02AA04 L02AA01 G03CC05 G03CB02
CAS number	56-53-1

Drug Targets

Name	Target Sequence	Pharmacological Action	Actions
Estrogen receptor beta	MDIKNSPSSLNSPSSYNCSQSILPLEHGSIYIPSSYVDSHHEYPAMTFYS...	unknown	agonist
Estrogen receptor	MTMTLHTKASGMALLHQIQGNELEPLNRPQLKIPLERPLGEVYLDSSKPA...	unknown	agonist
Estrogen-related receptor gamma	MDSVELCLPESFSLHYEEELLCRMSNKDRHIDSSCSSFIKTEPSSPASLT...	unknown	agonist
Steroid hormone receptor ERR1	MSSQVVGIEPLYIKAEPASPDSPKGSSETETEPPVALAPGPAPTRCLPGH...	unknown
Steroid hormone receptor ERR2	MSSDDRHLGSSCGSFIKTEPSSPSSGIDALSHHSPSGSSDASGGFGLALG...	unknown
Nuclear receptor coactivator 2	MSGMGENTSDPSRAETRKRKECPDQLGPSPKRNTEKRNREQENKYIEELA...	unknown
Nuclear receptor subfamily 1 group I member 2	MEVRPKESWNHADFVHCEDTESVPGKPSVNADEEVGGPQICRVCGDKATG...	unknown
Androgen receptor	MEVQLGLGRVYPRPPSKTYRGAFQNLFQSVREVIQNPGPRHPEAASAAPP...	unknown	antagonist
Sex hormone-binding globulin	MESRGPLATSRLLLLLLLLLLRHTRQGWALRPVLPTQSAHDPPAVHLSNG...	unknown
Cytochrome P450 3A4	MALIPDLAMETWLLLAVSLVLLYLYGTHSHGLFKKLGIPGPTPLPFLGNI...	unknown	substrate,inhibitor
Cytochrome P450 2C8	MEPFVVLVLCLSFMLLFSLWRQSCRRRKLPPGPTPLPIIGNMLQIDVKDI...	unknown	substrate,inhibitor
Cytochrome P450 2C9	MDSLVVLVLCLSCLLLLSLWRQSSGRGKLPPGPTPLPVIGNILQIGIKDI...	unknown	inhibitor
Cytochrome P450 2E1	MSALGVTVALLVWAAFLLLVSMWRQVHSSWNLPPGPFPLPIIGNLFQLEL...	unknown	inhibitor
Catechol O-methyltransferase	MPEAPPLLLAAVLLGLVLLVVLLLLLRHWGWGLCLIGWNEFILQPIHNLL...	unknown	substrate
Aromatase	MVLEMLNPIHYNITSIVPEAMPAATMPVLLLTGLFLLVWNYEGTSSIPGP...	unknown	inhibitor
Transthyretin	MASHRLLLLCLAGLVFVSEAGPTGTGESKCPLMVKVLDAVRGSPAINVAV...	unknown
Broad substrate specificity ATP-binding cassette transporter ABCG2	MSSSNVEVFIPVSQGNTNGFPATASNDLKAFTEGAVLSFHNICYRVKLKS...	unknown	inhibitor
ATP-dependent translocase ABCB1	MDLEGDRNGGAKKKNFFKLNNKSEKDKKEKKPTVSVFSMFRYSNWLDKLY...	unknown	substrate
Solute carrier organic anion transporter family member 1B1	MDQNQHLNKTAEAQPSENKKTRYCNGLKMFLAALSLSFIAKTLGAIIMKS...	unknown	inhibitor
Solute carrier organic anion transporter family member 2B1	MGPRIGPAGEVPQVPDKETKATMGTENTPGGKASPDPQDVRPSVFHNIKL...	unknown	substrate
Bile salt export pump	MSDSVILRSIKKFGEENDGFESDKSYNNDKKSRLQDEKKGDGVRVGFFQL...	unknown	substrate
View More

Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS. Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682

Related Resource References

Resource Name	Reference
Pharos	CHEMBL411
PubChem	448537
ChEMBL	CHEMBL411
ChEBI	CHEBI:41922, CHEBI:92795
CCDC/CSD	ESTILO03, DESTDM01, XEHNON, XEHPAB, XEHNED, NOCTAD, NOCSUW, NOCSIK, ETSTIL10, NOCTEH, NOCSAC, ESTILO02
COD	2102206, 2102207, 2102209, 2102208, 2102210